Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
Monster Beverage
MNST
|
+$584M |
| 3 |
Intercontinental Exchange
ICE
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$386M |
| 5 |
Johnson & Johnson
JNJ
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.95B |
| 2 |
Texas Instruments
TXN
|
+$750M |
| 3 |
Deere & Co
DE
|
+$539M |
| 4 |
Microsoft
MSFT
|
+$507M |
| 5 |
Meta Platforms (Facebook)
META
|
+$488M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.99% |
| 2 | Healthcare | 19.86% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.49% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
176
DELISTED
Avidity Biosciences
RNAM
| $225M | 0.12% |
4,896,166
+1,239,323
| +34% | +$53.8M |
|
177
General Dynamics
GD
$105B
| $223M | 0.11% |
737,105
-316,457
| -30% | -$93M |
|
178
Core & Main
CNM
$8.17B
| $223M | 0.11% |
5,015,867
-27,862
| -0.6% | -$1.33M |
|
179
Burlington
BURL
$22.5B
| $222M | 0.11% |
842,188
-239,957
| -22% | -$62.1M |
|
180
Amphenol
APH
$184B
| $217M | 0.11% |
3,323,021
-23,081
| -0.7% | -$1.5M |
|
181
Vanguard S&P 500 ETF
VOO
$968B
| $214M | 0.11% |
406,460
-23,953
| -6% | -$12.2M |
|
182
Sotera Health
SHC
$4.92B
| $212M | 0.11% |
12,668,790
-1,824,046
| -13% | -$26.6M |
|
183
Zai Lab
ZLAB
$2.1B
| $211M | 0.11% |
8,760,074
+2,232,507
| +34% | +$42.2M |
|
184
Ryan Specialty Holdings
RYAN
$5.59B
| $209M | 0.11% |
3,148,916
+13,986
| +0.4% | +$874K |
|
185
Walker & Dunlop
WD
$1.69B
| $209M | 0.11% |
1,836,529
+502
| +0% | +$52.5K |
|
186
Wayfair
W
$12.5B
| $207M | 0.11% |
3,691,462
+327,944
| +10% | +$15.8M |
|
|
SLNO
187
DELISTED
Soleno Therapeutics
SLNO
| $206M | 0.11% |
4,081,099
+722,226
| +22% | +$34.6M |
|
188
Goldman Sachs
GS
$309B
| $205M | 0.11% |
414,867
+251,972
| +155% | +$123M |
|
|
AKRO
189
DELISTED
Akero Therapeutics
AKRO
| $203M | 0.1% |
7,077,478
+201,225
| +3% | +$5.25M |
|
190
Elevance Health
ELV
$82.1B
| $201M | 0.1% |
386,404
-1,731
| -0.4% | -$925K |
|
191
IBM
IBM
$204B
| $193M | 0.1% |
871,064
+183,141
| +27% | +$35.9M |
|
192
Microchip Technology
MCHP
$42.3B
| $191M | 0.1% |
2,384,306
-1,122,219
| -32% | -$92.6M |
|
193
Palo Alto Networks
PANW
$259B
| $191M | 0.1% |
1,115,550
+179,438
| +19% | +$30.2M |
|
194
Coca-Cola
KO
$362B
| $190M | 0.1% |
2,648,552
-101,657
| -4% | -$6.96M |
|
195
Motorola Solutions
MSI
$70.3B
| $188M | 0.1% |
419,161
-7,675
| -2% | -$3.2M |
|
196
Bristol-Myers Squibb
BMY
$128B
| $184M | 0.09% |
3,554,758
+3,107,672
| +695% | +$146M |
|
197
OSI Systems
OSIS
$3.58B
| $184M | 0.09% |
1,209,168
+29,858
| +3% | +$4.29M |
|
198
Sensient Technologies
SXT
$5.32B
| $179M | 0.09% |
2,231,803
+2,053
| +0.1% | +$156K |
|
199
Surgery Partners
SGRY
$1.98B
| $177M | 0.09% |
5,497,368
+1,184,450
| +27% | +$35M |
|
200
Realty Income
O
$61.1B
| $175M | 0.09% |
2,760,182
+2,675,266
| +3,150% | +$159M |
|
Similar funds
Janus Henderson Group's Q3 2024 Portfolio in Review
As of Q3 2024, Janus Henderson Group held 2,584 positions worth $195B, up 4.6% from $187B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.7%. Janus Henderson Group opened 66 new positions and exited 56, leaving the 2,584-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2024 buy was Janus Henderson Emerging Markets Debt Hard Currency ETF: 4,369,165 shares worth $228M.
- Janus Henderson Group added most to Broadcom in Q3 2024, an estimated $605M increase.
- Janus Henderson Group's biggest Q3 2024 reduction was Texas Instruments, cutting an estimated $750M.
- Janus Henderson Group fully exited Lam Research in Q3 2024, selling an estimated $1.95B.
- Janus Henderson Group's ten largest holdings make up 30% of its $195B portfolio in Q3 2024.
- Janus Henderson Group opened 66 new positions and closed 56 in Q3 2024.
- Janus Henderson Group's portfolio value rose 4.6% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q3 2024, filed 14 Nov 2024.